Nucleai

StratifAI

This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.

ViewsML

This company develops an artificial intelligence platform providing virtual biomarker staining of pathology images for biopharmaceutical researchers, clinical trial teams and diagnostic laboratories.

Micrographia Bio

This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.

Enable Medicine

Enable Medicine provides a cloud-based spatial biology platform for life science researchers and pharmaceutical companies to analyse cellular data and discover new drug targets.

MultivisionDx

This company develops AI-powered spatial biology platforms and diagnostic tests for clinicians and researchers to improve treatment decisions for solid cancer patients.

Panakeia

The company develops artificial intelligence software to provide rapid molecular cancer biomarker analysis from tissue images for hospitals and pharmaceutical research organisations.

Preview Health

This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.

intoDNA

This company develops an AI-powered platform for detecting and quantifying DNA damage in cells to support pharmaceutical companies with drug development and diagnostics.